• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Abbott Laboratories (NY:ABT)

    123.84 +0.22 (+0.18%)
    Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Abbott Laboratories

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    44 45 Next >
    AI's Power Problem
    AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast? 
    Via The Motley Fool
    Topics Artificial Intelligence Economy Energy
    ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
    Via MarketBeat
    Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook
    Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled. 
    Via Investor's Business Daily
    Should You Buy DexCom Stock Before Oct. 31?
    The company hasn't had a great year. Is it about to turn things around? 
    Via The Motley Fool
    Topics Lawsuit
    Recent Corporate Earnings Fuel Market Rally to Record Highs: AI and Rate Cut Hopes Drive Optimism
    The third-quarter (Q3) 2025 earnings season has delivered a powerful jolt to global financial markets, propelling major U.S. indices to unprecedented record highs. A wave of surprisingly robust... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    Is the Market Bullish or Bearish on Abbott Laboratories?
     
    Via Benzinga
    Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
    Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker. 
    Via The Motley Fool
    Topics Intellectual Property
    Abbott Laboratories (NYSE:ABT): A Strong Dividend Stock for Reliable Income and Growth
    Discover Abbott Laboratories (ABT), a top dividend stock with a 1.87% yield, 11% growth, and a strong financial profile for reliable income. 
    Via Chartmill
    Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
    New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
    Via MarketMinute
    Topics Earnings Supply Chain
    EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards
    Trinity Capital Inc. announced a financing agreement with Bobbie, an organic infant nutrition company, to boost production capacity and ensure wider distribution of its products. 
    Via Benzinga
    1 Safe-and-Steady Stock with Exciting Potential and 2 We Question
    Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
    Via StockStory
    A Look Into Abbott Laboratories Inc's Price Over Earnings
     
    Via Benzinga
    Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
    Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the... 
    Via MarketMinute
    Topics Artificial Intelligence Earnings Economy
    The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call
    Abbott Laboratories’ third quarter results met Wall Street’s expectations for both revenue and non-GAAP profit, but the market reacted negatively, with shares declining over 4%. Management pointed to... 
    Via StockStory
    Topics Earnings
    U.S. Job Growth Stalls at 0.1%: Echoes of 2009 as Economy Navigates Fragile Labor Market
    The U.S. economy is currently grappling with a significant deceleration in job growth, with proprietary data from investment giant Vanguard revealing a meager 0.1% growth rate for seven of the first... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Immigration
    Abbott Laboratories' October Price Plunge Is a Signal to Buy
    Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend. 
    Via MarketBeat
    Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength
    Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion. 
    Via Benzinga
    These Analysts Revise Their Forecasts On Abbott Following Q3 Results
     
    Via Benzinga
    Earnings Season Fuels Market Optimism Amidst Economic Headwinds
    As the Q3 2025 earnings season unfolds, corporate America is delivering a powerful narrative of resilience and growth, significantly influencing overall stock market movements. Despite a complex... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Workforce
    Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
    Investors should be able to count on these stocks to deliver steady and growing income over the long term. 
    Via The Motley Fool
    ABT Q3 Deep Dive: Q3 Results in Line with Expectations, Product Pipeline and Market Dynamics Shape Outlook
    Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30... 
    Via StockStory
    Topics World Trade
    U.S. Stocks End Mixed Amidst Trade Tensions, Dovish Fed Hopes, and Robust Earnings
    The U.S. stock market closed with a mixed performance recently, reflecting a complex and dynamic environment where investor sentiment is being pulled in multiple directions. As of October 15, 2025, a... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    Why Abbott Laboratories (ABT) Stock Is Down Today
    Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not... 
    Via StockStory
    Gold Gains Over 1%; Abbott Shares Fall After Q3 Results
     
    Via Benzinga
    Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025
    In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Wednesday's session: top gainers and losers in the S&P500 index
    Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
    Via Chartmill
    Abbott Laboratories Remains In Favor With London Investment Manager, New Filing Shows
    Via The Motley Fool
    Topics Regulatory Compliance
    Bank Earnings Lift Wall Street, Gold Hits $4,200: What's Moving Markets Wednesday?
    Wall Street rose on Wednesday, with investor optimism lifted by strong bank and corporate earnings alongside growing expectations for further Federal Reserve rate cuts — keeping trade concerns... 
    Via Benzinga
    Topics Economy
    These S&P500 stocks are gapping in today's session
    Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session. 
    Via Chartmill
    1 No-Brainer Dividend Stock to Buy and Hold Forever
    This is about as safe as a dividend can be. 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    44 45 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.